RSNA 2020 CT Preview

Road to RSNA 2020: CT

By Kate Madden Yee, staff writer
November 17, 2020

The COVID-19 pandemic has highlighted CT's usefulness as a diagnostic tool -- especially in the early days of the outbreak, when reverse transcription polymerase chain reaction tests were scarce and results were delayed.

As the year has progressed, CT has continued to show its value as clinicians track COVID-19 patients after recovery. Attendees at the virtual RSNA 2020 meeting will hear results from research that demonstrates CT's efficacy in this regard.

Meanwhile, other science and educational sessions at RSNA 2020 will cover topics such as cardiac CT, assessing patients' responses to treatment using PET/CT, and innovations in dual- and multienergy CT. Researchers will also explore questions such as whether fractional flow reserve CT for stenosis on coronary CT angiography can replace CT perfusion, as well as whether triple-rule-out chest CT in the emergency room can be the "one-stop" solution for evaluating chest pain.

Also look for research that reviews the use of molecular imaging with CT -- one session in particular will address abdominal and pelvic imaging -- and how radiologists are using artificial intelligence and radiomics for CT in clinical practice.

Our pre-RSNA coverage on CT offers insights into the pivotal role the modality plays in the imaging enterprise, including perspectives from RSNA subcommittee chairs and other experts in the field.

CT shows its value in the COVID-19 crisis
At the start of the COVID-19 pandemic, as researchers and clinicians rushed to determine the best ways to diagnose and treat the illness, chest CT proved to be a valuable tool -- particularly when reverse transcription polymerase chain reaction testing wasn't easily available or results were delayed.  Discuss
Canon to showcase CT portfolio featuring deep-learning innovation during RSNA 2020
At this year's RSNA annual meeting, Canon Medical Systems USA will demonstrate its CT innovations on its unique, immersive virtual booth, creating a one-of-a-kind digital experience for visitors.  Discuss
COVID-19, AI, and dose reduction top RSNA's CT agenda
In 2020, the COVID-19 pandemic has shaped the practice of imaging across all modalities, and CT is no exception. At the upcoming RSNA 2020 meeting, attendees are likely to hear significant discussion of how CT fits into the continuum of COVID-19 diagnosis and tracking. CT will also have its time in the spotlight for a range of other applications, such as its use with artificial intelligence (AI) to spot pulmonary embolism.  Discuss